Audible Article by Jagpal Singh Klair, James Vancura, and Arvind R. Murali

PRO: Patients with Chronic Hepatitis B in Immune-Tolerant Phase Should Be Treated

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share PRO: Patients with Chronic Hepatitis B in Immune-Tolerant Phase Should Be Treated

Sign up to save your podcasts

PRO: Patients with Chronic Hepatitis B in Immune-Tolerant Phase Should Be Treated

PRO: Patients with Chronic Hepatitis B in Immune-Tolerant Phase Should Be Treated